Arboretum
11 employees on LinkedIn · 1 known investors
Arboretum provides genetic testing programs and patient registry infrastructure for healthcare systems to implement precision medicine for cardiovascular disease, cancer, and metabolic conditions. The company enables clinical integration and translational research to accelerate precision medicine trials.
Investors · 1
Competitors · 4
by search overlapPrecision BioSciences10 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
bio10 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Aro Biotherapeutics7 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Pillar Biosciences6 shared keywordsPillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Companies competing with Arboretum for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Arboretum do?
- Arboretum provides genetic testing programs and patient registry infrastructure for healthcare systems to implement precision medicine for cardiovascular disease, cancer, and metabolic conditions. The company enables clinical integration and translational research to accelerate precision medicine trials.
- Who are Arboretum's investors?
- Arboretum's investors include .406 Ventures.